About Avalere: Affiliations and Partners

With the passage of health reform Avalere continues to diversify its staff and customer base. Focus on reform includes increased consideration of change in commercial insurance markets, expansion in the purview of Medicaid, investments in Comparative Effectiveness Research, and delivery system changes. Avalere also launches EBM Navigator - an innovative suite of on-line tools designed to help leading organizations anticipate market and regulatory change in evidence-based medicine. Avalere remains energized about continuing to grow the firm in support of its mission and vision.
Intensive policy discussions continue to energize Avalere. Passage of the stimulus bill and subsequent government focus on health information technology, comparative effectiveness research, and entitlement expansion pose business challenges to healthcare companies. Health reform discussions heat up, and Avalere’s client base continues to grow.
Avalere initiates a focus on serving financial services companies with investments and/or interest in healthcare. The firm also launches offerings in health economics and outcomes research, hiring concentrated clinical and methodological expertise.

In April, ABS Capital Partners, a leading late-stage growth company investor, purchases a minority ownership share of Avalere. At the same time, Avalere grants senior members of the firm equity in the company. This step further institutionalizes Avalere and establishes the firm as a stable, well-capitalized organization that is majority owned by its employees.
Avalere creates a group focused on Data and Analytics to concentrate the firm’s resources in modeling, database evaluation, and related technical expertise. The group today is home to a talented core of experts in healthcare data, generating strategy around database design as well as analysis of data key to understanding the intersection of healthcare business and policy.
Avalere creates a group focused exclusively on Evidence Based Medicine. Today, the group has more than 25 staff, allowing for deep concentration on clinical, research, and business expertise to serve virtually every type of organization interested in healthcare quality and clinical effectiveness in practice.
In May, the company renames itself Avalere Health, a term borrowing from the Latin word “valere,” meaning “strong and of good health.” The firm crafts a logo based on the migration of geese – they travel in a V formation to fly longer and stronger – to reflect its approach and commitment to teamwork, its vibrant culture, and the positive possibility of collaboration.
With its steady growth and development, Avalere re-organizes, creating practice areas focused on its substantive areas of expertise. Content depth and proactivity around substance remain a major differentiator for Avalere.
The Medicare Modernization Act passes, making Medicare Part D a major substantive focus of Avalere’s clients. Avalere develops deep expertise on both the legislation and regulation implementing the new benefit. Avalere also launches DataFrame®, the firm’s first proprietary database product focused on the changing Medicare marketplace. Avalere further diversifies its customer base to reflect all commercial entities affected by the law, in addition to patient groups and other non-profit organizations whose constituents were the focus of these changes.
Avalere hosts its first public substantive event – focused on payment for new and emerging medical technology – at Duke University. This event serves as a springboard for Avalere educational programs, which proliferate on a national level and continue to provide an objective, actionable venue for dialogue around important policy and business issues.
By December, Avalere assembles a diverse staff of 17, with experience working in the Fortune 500 healthcare companies, White House OMB, the Centers for Medicare and Medicaid Services, and other leading healthcare organizations. The team dives deeply into the substance of Medicare and Medicaid policy on behalf of commercial customers, government, and foundations.
After leaving the White House Office and Management and Budget, where he served as Associate Director for Health, Dan Mendelson starts Avalere, then known as Health Strategies LLC. The company is created to address substantive issues at the intersection of business strategy and public policy in healthcare. Initial clients include Fortune 500 healthcare companies and major medical foundations.


		With the passage of health reform Avalere continues to diversify its staff and customer base. Focus on reform includes increased consideration of change in commercial insurance markets, expansion in the purview of Medicaid, investments in Comparative Effectiveness Research, and delivery system changes. Avalere also launches EBM Navigator - an innovative suite of on-line tools designed to help leading organizations anticipate market and regulatory change in evidence-based medicine. Avalere remains energized about continuing to grow the firm in support of its mission and vision. Intensive policy discussions continue to energize Avalere. Passage of the stimulus bill and subsequent government focus on health information technology, comparative effectiveness research, and entitlement expansion pose business challenges to healthcare companies. Health reform discussions heat up, and Avalere’s client base continues to grow. Avalere initiates a focus on serving financial services companies with investments and/or interest in healthcare. The firm also launches offerings in health economics and outcomes research, hiring concentrated clinical and methodological expertise. In April, ABS Capital Partners, a leading late-stage growth company investor, purchases a minority ownership share of Avalere. At the same time, Avalere grants senior members of the firm equity in the company. This step further institutionalizes Avalere and establishes the firm as a stable, well-capitalized organization that is majority owned by its employees. Avalere creates a group focused on Data and Analytics to concentrate the firm’s resources in modeling, database evaluation, and related technical expertise. The group today is home to a talented core of experts in healthcare data, generating strategy around database design as well as analysis of data key to understanding the intersection of healthcare business and policy. Avalere creates a group focused exclusively on Evidence Based Medicine. Today, the group has more than 25 staff, allowing for deep concentration on clinical, research, and business expertise to serve virtually every type of organization interested in healthcare quality and clinical effectiveness in practice. In May, the company renames itself Avalere Health, a term borrowing from the Latin word “valere,” meaning “strong and of good health.” The firm crafts a logo based on the migration of geese – they travel in a V formation to fly longer and stronger – to reflect its approach and commitment to teamwork, its vibrant culture, and the positive possibility of collaboration. With its steady growth and development, Avalere re-organizes, creating practice areas focused on its substantive areas of expertise. Content depth and proactivity around substance remain a major differentiator for Avalere. The Medicare Modernization Act passes, making Medicare Part D a major substantive focus of Avalere’s clients. Avalere develops deep expertise on both the legislation and regulation implementing the new benefit. Avalere also launches DataFrame®, the firm’s first proprietary database product focused on the changing Medicare marketplace. Avalere further diversifies its customer base to reflect all commercial entities affected by the law, in addition to patient groups and other non-profit organizations whose constituents were the focus of these changes. Avalere hosts its first public substantive event – focused on payment for new and emerging medical technology – at Duke University. This event serves as a springboard for Avalere educational programs, which proliferate on a national level and continue to provide an objective, actionable venue for dialogue around important policy and business issues. By December, Avalere assembles a diverse staff of 17, with experience working in the Fortune 500 healthcare companies, White House OMB, the Centers for Medicare and Medicaid Services, and other leading healthcare organizations. The team dives deeply into the substance of Medicare and Medicaid policy on behalf of commercial customers, government, and foundations. After leaving the White House Office and Management and Budget, where he served as Associate Director for Health, Dan Mendelson starts Avalere, then known as Health Strategies LLC. The company is created to address substantive issues at the intersection of business strategy and public policy in healthcare. Initial clients include Fortune 500 healthcare companies and major medical foundations.